Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2021-10-20 Environmental & Social …
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
Global Bioenergies makes breakthrough on the road toward biojet fuel
Environmental & Social Information Classification · 99% confidence The document is a press release dated October 20, 2021, detailing a major technical advance in Global Bioenergies' process for converting plant-based feedstocks into isobutene, specifically targeting biojet fuel and cosmetics markets. It discusses scientific breakthroughs, future production plans (Pomacle unit, larger plant for 2024), regulatory approvals (ASTM), and strategic outlook. This content is characteristic of an announcement intended to inform investors and the public about significant operational and strategic developments, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed management discussion (MDA). Since it is a general announcement about company progress and strategy, and does not fit the specific categories like Capital (CAP), Dividend (DIV), or Director Dealing (DIRS), it best fits the general 'Regulatory Filings' (RNS) category as a broad corporate announcement, or potentially an Investor Presentation (IP) if it were structured as slides, but given the press release format, RNS is the most appropriate fallback for significant, non-standard announcements.
2021-10-20 English
Global Bioenergies publie ses résultats semestriels
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first half of 2021 (semestriel). It includes detailed financial statements (income statement, balance sheet), management commentary, and analysis of business trends. It is not a mere announcement (RPA) as it contains substantive financial data and tables. Therefore, it is classified as an Interim/Quarterly Report. H1 2021
2021-09-28 French
Global Bioenergies publishes half-year financial results
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first half of 2021 (H1 2021). It contains detailed consolidated financial statements, including a Profit & Loss account, Balance Sheet, and breakdowns of operating expenses and industrialization costs. It also provides management commentary on business trends, highlights of the period, and strategic outlook. Although it mentions that the full report is available on the website, the document itself provides the substantive financial data and analysis required for an Interim/Quarterly Report, distinguishing it from a mere announcement. H1 2021
2021-09-28 English
Global Bioenergies : lancement de la gamme lèvres de la marque LAST
Regulatory Filings Classification · 93% confidence The document is a press release dated September 14, 2021, announcing the expansion of the LAST brand's lip product range, featuring liquid lipsticks that utilize Global Bioenergies' naturally derived isododecane. It includes quotes from management and contact information for Investor Relations and Press. This type of announcement, detailing a new product launch and business development, does not fit the specific financial filing codes (like 10-K, ER, IR, CAP, etc.). It is a general corporate announcement. Since it is not a standard regulatory filing (RNS) or a report announcement (RPA), and it details a business/product update, it is best classified as a general Regulatory Filing (RNS) as the fallback for non-standard corporate news releases, although it shares characteristics with a general press release not explicitly covered by the provided definitions. Given the options, RNS serves as the most appropriate catch-all for significant, non-financial-report corporate news.
2021-09-14 French
Global Bioenergies launches lip make-up range for its LAST cosmetics brand
Regulatory Filings Classification · 95% confidence The document is explicitly labeled as a "PRESS RELEASE" dated September 14, 2021. It announces a new product launch (lip make-up range) for the company's cosmetics brand, LAST, detailing product features and quoting management. This type of announcement, which communicates operational news and product developments to the public and investors, does not fit the specific financial reporting categories (10-K, IR, ER, etc.). Since it is a general corporate announcement that doesn't fit the other specific categories like M&A (TAR), Director Dealing (DIRS), or Capital Change (CAP), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general announcement category for non-standard filings.
2021-09-14 English
Publication in Nature Communications of a paper describing the mechanism of enzymes yielding renewable isobutene
Regulatory Filings Classification · 95% confidence The document is a press release dated September 6, 2021, announcing the publication of a scientific paper in *Nature Communications* detailing collaborative work between Global Bioenergies and the University of Manchester regarding the mechanism of enzymes yielding renewable isobutene. It discusses scientific findings, intellectual property rights, and provides contact information for Investor Relations. This type of announcement, focusing on scientific/technical achievements and their industrial relevance, does not fit neatly into standard SEC filings (like 10-K, ER, IR) or common corporate actions (like DIV, CAP, MANG). It is a general corporate announcement regarding research progress and publication, which aligns best with the 'Regulatory Filings' (RNS) category as a general regulatory/corporate disclosure that doesn't match a more specific code.
2021-09-06 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.